EcoDrugPlus

Toll-Like Receptor 2

Ensembl ID : ENSACLG00000015691
Gene Symbol: LOC113019433
3 Cross references
211 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSACLG00000007248
Gene Symbol: LOC113021719
3 Cross references
550 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSACLG00000024893
Gene Symbol: TRPA1
3 Cross references
201 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSACLG00000011604
Gene Symbol: TPH1
3 Cross references
202 Possible Orthologues:

Tryptophan Hydroxylase 1b

Ensembl ID : ENSACLG00000000631
Gene Symbol: TPH1B
1 Cross references
177 Possible Orthologues:

Tubulin Alpha 1b

Ensembl ID : ENSACLG00000016619
Gene Symbol: TUBA1B
1 Cross references
192 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSACLG00000018133
Gene Symbol: LOC113008342
3 Cross references
152 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSACLG00000018150
Gene Symbol: LOC113008341
2 Cross references
156 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSACLG00000012140
Gene Symbol: LOC113015968
2 Cross references
144 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSACLG00000022807
Gene Symbol: TUBB
2 Cross references
183 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSACLG00000021381
Gene Symbol: LOC113010411
3 Cross references
301 Possible Orthologues:

Tubulin, Beta 5

Ensembl ID : ENSACLG00000025503
Gene Symbol: TUBB5
1 Cross references
113 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).